Emerging evidence reveal that the activity or expression of SERCA was compromised in metabolic syndromes, resulting in ER stress and apoptosis, while the restoration of SERCA2 activity or expression ameliorated ER stress and in turn improved metabolic abnormalities14, 40. This evidence concerns the gene ATP2A2 and metabolic syndrome.